Clinical Trial Update: RNS System LGS Feasibility Study [Phase 2]

View source ↗

Summary

The RNS System LGS feasibility study (Phase 2) is currently active but not recruiting, evaluating responsive neurostimulation for Lennox-Gastaut syndrome and ep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• RNS System (responsive neurostimulation device)

Snippet

Sponsor: NeuroPace | Conditions: Epilepsy, Lennox Gastaut Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING